Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Testa

Showing results (551-560 of 588) with videos related to

Pageof 59
Sort By:
Molecular Cancer Research : MCR|January 27, 2022
Inactivation of p21-Activated Kinase 2 (Pak2) Inhibits the Development of Nf2-Deficient Tumors by Restricting Downstream Hedgehog and Wnt SignalingEleonora Sementino, Yuwaraj Kadariya, Mitchell Cheung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2007
Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group StudyLinda L Garland, Cathryn Rankin, David R Gandara, et al.
Cancer Biology & Therapy|March 3, 2020
Overall tumor genomic instability: an important predictor of recurrence-free survival in patients with localized clear cell renal cell carcinomaAndres F Correa, Karen J Ruth, Tahseen Al-Saleem, et al.
American Journal of Respiratory Cell and Molecular Biology|April 2, 2011
An extracellular signal-regulated kinase 2 survival pathway mediates resistance of human mesothelioma cells to asbestos-induced injuryArti Shukla, Trisha F Barrett, Maximilian B MacPherson, et al.
Frontiers in Environmental Science|December 3, 2020
Challenging Global Waste Management - Bioremediation to Detoxify AsbestosShannon L Wallis, Edward A Emmett, Robyn Hardy, et al.
Blood Transfusion = Trasfusione Del Sangue|December 8, 2023
Ten years of a neonatal screening program for hemoglobinopathies in Friuli-Venezia Giulia: first regional experience in ItalyEpifania R Testa, Margherita Robazza, Francesca Barbieri, et al.
Cancer Research|June 2, 2019
Inactivation of <i>Bap1</i> Cooperates with Losses of <i>Nf2</i> and <i>Cdkn2a</i> to Drive the Development of Pleural Malignant Mesothelioma in Conditional Mouse ModelsAnna-Mariya Kukuyan, Eleonora Sementino, Yuwaraj Kadariya, et al.
Genes, Chromosomes & Cancer|February 15, 2001
Human hepatocellular carcinoma is characterized by a highly consistent pattern of genomic imbalances, including frequent loss of 16q23.1-24.1B R Balsara, J Pei, A De Rienzo, et al.
Cancer Research|June 15, 2014
Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesotheliomaJinfei Xu, Yuwaraj Kadariya, Mitchell Cheung, et al.
Molecular Cancer Therapeutics|July 29, 2010
Vascular endothelial growth factor is a promising therapeutic target for the treatment of clear cell carcinoma of the ovarySeiji Mabuchi, Chiaki Kawase, Deborah A Altomare, et al.
Pageof 59

Showing results (551-560 of 588) with videos related to

Sort By:
Pageof 59
Molecular Cancer Research : MCR|January 27, 2022
Inactivation of p21-Activated Kinase 2 (Pak2) Inhibits the Development of Nf2-Deficient Tumors by Restricting Downstream Hedgehog and Wnt SignalingEleonora Sementino, Yuwaraj Kadariya, Mitchell Cheung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2007
Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group StudyLinda L Garland, Cathryn Rankin, David R Gandara, et al.
Cancer Biology & Therapy|March 3, 2020
Overall tumor genomic instability: an important predictor of recurrence-free survival in patients with localized clear cell renal cell carcinomaAndres F Correa, Karen J Ruth, Tahseen Al-Saleem, et al.
American Journal of Respiratory Cell and Molecular Biology|April 2, 2011
An extracellular signal-regulated kinase 2 survival pathway mediates resistance of human mesothelioma cells to asbestos-induced injuryArti Shukla, Trisha F Barrett, Maximilian B MacPherson, et al.
Frontiers in Environmental Science|December 3, 2020
Challenging Global Waste Management - Bioremediation to Detoxify AsbestosShannon L Wallis, Edward A Emmett, Robyn Hardy, et al.
Blood Transfusion = Trasfusione Del Sangue|December 8, 2023
Ten years of a neonatal screening program for hemoglobinopathies in Friuli-Venezia Giulia: first regional experience in ItalyEpifania R Testa, Margherita Robazza, Francesca Barbieri, et al.
Cancer Research|June 2, 2019
Inactivation of <i>Bap1</i> Cooperates with Losses of <i>Nf2</i> and <i>Cdkn2a</i> to Drive the Development of Pleural Malignant Mesothelioma in Conditional Mouse ModelsAnna-Mariya Kukuyan, Eleonora Sementino, Yuwaraj Kadariya, et al.
Genes, Chromosomes & Cancer|February 15, 2001
Human hepatocellular carcinoma is characterized by a highly consistent pattern of genomic imbalances, including frequent loss of 16q23.1-24.1B R Balsara, J Pei, A De Rienzo, et al.
Cancer Research|June 15, 2014
Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesotheliomaJinfei Xu, Yuwaraj Kadariya, Mitchell Cheung, et al.
Molecular Cancer Therapeutics|July 29, 2010
Vascular endothelial growth factor is a promising therapeutic target for the treatment of clear cell carcinoma of the ovarySeiji Mabuchi, Chiaki Kawase, Deborah A Altomare, et al.
Pageof 59